However, whether IL-17 can affect differentiation and function of Th9 cells in MPE remains unknown. The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9-dependent mechanism. It was found that Th9 and Th2 cells were decreased in MPE from IL-17 -/-mice as compared with wild type mice. IL-17 deficiency inhibited Th9 and Th2 cell differentiation via suppressing transcription factors IRF4 and GATA-3, respectively. IL-17 deficiency enhanced MPE formation by promoting angiogenesis and proliferation of pleural tumors, and thus accelerated the death of mice bearing MPE. The in vivo administration of anti-IL-9 neutralizing mAb accelerated the death of WT mice; whereas administration of exogenous IL-9 improved the survival of IL-17 -/-mice. Our data provide the first definitive evidence that IL-17 promotes the differentiation of Th9 and Th2 cells in MPE. Our findings also demonstrate that IL-17 inhibits the formation of MPE and improves the survival of mice bearing MPE via an IL-9-dependent mechanism. malignant pleural effusion, interleukin 17, Th9 cells Citation:
INTRODUCTION
IL-9, a member of the IL-2 cytokine family, is produced by naïve CD4 + T lymphocytes in response to IL-4 and TGF- (Dardalhon et al., 2008; Veldhoen et al., 2008) . IL-9 has been suggested to possess a functional role in some malignant lymphomas, such as Hodgkin's disease and large-cell anaplastic lymphoma (Fischer et al., 2003; Merz et al., 1991) . It has been demonstrated that IL-9 plays a role during tumor genesis because dysregulated IL-9 response results in autonomous cell growth and malignant transformation of lymphoid cells associated with constitutive activation of the Jak/STAT pathway (Knoops and Renauld, 2004) .
Malignant pleural effusion (MPE) is a frequent and clinically significant systemic manifestation of various malignancies that adversely affects patient survival and quality of life (Kastelik, 2013; Roberts et al., 2010) . It has been well documented that CD4 + T cell dominance occurs in MPE. Naïve CD4 + T cells become activated and differentiate into effector T helper (Th) cell subgroups, depending on the antigens and cytokine microenvironment they encounter. Our previous studies have demonstrated that several subgroups of CD4 + T cells, such as regulatory T cells (Tregs) (Chen et al., 2005) , IL-17-producing CD4 + T cells (Th17 cells) (Ye et al., 2010) , + T cells (Th22 cells) (Ye et al., 2012a) , and IL-9-producing CD4 + T cells (Th9 cells) (Ye et al., 2012b) , play important immune regulatory roles in the pathogenesis of human MPE.
The relationship between Th9 and Th17 cells is of particular interest, and their immune regulation is often linked to proinflammatory and malignant processes. IL-9 can be produced by Th17 cells, which secrete mainly IL-17A and IL-17F (Beriou et al., 2010) . On the other hand, IL-9 is able to induce Th17 cells to differentiate (Elyaman et al., 2009) , and acts as a mediator of Th17 cell-associated inflammation and autoimmune process (Nowak et al., 2009; Singh et al., 2013) . Our previous studies revealed that both Th17 and Th9 cells are increased in MPE which is promoted by local proinflammatory cytokines, and these Th cells exert an important immune regulation on lung cancer cells in tumor environment (Ye et al., 2010 (Ye et al., , 2012b . More recently, we have demonstrated that IL-17 deficiency promotes angiogenesis and proliferation activity of pleural tumors as well as pleural vascular permeability, and thus promotes MPE formation in the animal models of MPE using IL-17 / mice (Lin et al., 2014) . In the present study, we were prompted to explore the impact of IL-17 on the differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9-dependent mechanism.
RESULTS

IL-17 inhibited MPE formation
In the previous study (Lin et al., 2014) , we have demonstrated that more pleural tumor foci and bloody MPE are found in IL-17 / mice as compared with WT mice 14 days after intrapleural injection of LLC cells. Here once again we confirmed that radiotracer uptake was significantly increased on FDG-PET scanning in IL-17 / mice ( Figure   1A ). Furthermore, we found in the current study for the first time that the maximum standardized uptake value (SUV max ) in WT mice was much lower than that in WT mice injected intraperitoneally with anti-IL-17 neutralizing mAb (P=0.046); and that SUV max in IL-17 / mice injected intraperitoneally with rmIL-17 was much lower than that in IL-17 / mice (P<0.001) ( Figure 1A and B). These data indicate that both endogenous and exogenous IL-17 are capable of inhibiting the development of MPE. As reported in our previous paper (Lin et al., 2014) , expressions of both CD34 and Ki-67 in pleural tumors are increased in IL-17 / mice. We extended these work and further observed that intraperitoneal injection of anti-IL-17 mAb in WT mice significantly increased the numbers of both CD34 + ( Figure 2A ) and Ki-67 + cells (P<0.01) ( Figure   2B ); while intraperitoneal injection of rmIL17 in IL-17 
Th9 and Th2 cells were significantly increased in MPE
We next investigated the distribution of Th9 cells in relation to Th2 cells in MPE using flow cytometry. In WT mice, a significant increase in Th9 cells ( Figure 3A and B) and Th2 cells ( Figures 3A and 2C) 
Expressions of IL-9, IL-4, IRF4, and GATA-3 mRNA in MPE
The mRNA expression of IL-9 ( Figure 4A ) and was much lower in MPE from IL-17 / mice than those from WT mice (P<0.01). The intraperitoneal injection of anti-IL-17 mAb in WT mice significantly decreased mRNA expression of IL-9 and IL-4, whereas the intraperitoneal injection of rmIL17 in IL-17 / mice significantly increased mRNA expression of IL-9 and IL-4 (P<0.01). In parallel to the change in mRNA expression of IL-9 and IL-4, very similar change patterns in mRNA expression of IRF4 ( Figure 4C ) and GATA-3 ( Figure 4D ) were also observed (P<0.01).
IL-17 affects survival of mice bearing MPE via IL-9-dependent mechanism
The median survival times of WT, WT+anti-IL-9, IL-17
, and IL-17 / +rmIL-9 mice bearing MPE were 26.0, 19.0, 20.0, and 26.0 days, respectively. The overall log rank test for survival among these four groups was significant (P<0.001). Pair-wise log rank tests showed that the survival of IL-17 / mice was much shorter than that of WT mice (P<0.001). Intraperitoneal injection of anti-IL-9 mAb accelerated the death of WT mice (P<0.001), whereas intraperitoneal injection of rmIL-9 improved the survival of IL-17 / mice (P<0.001) ( Figure 5 ). The survival of the two control groups (isotype mAb control for WT+anti-IL-9 group and PBS containing 0.1% albumin control for IL-17
+rmIL-9 group) was similar to that of WT mice (data not shown). 
DISCUSSION
In the presence of TGF-1, IL-9 differentiates naïve CD4 + T cells into Th17 cells; IL-9 also enhances the suppressive functions of Tregs in vitro. The mechanism by which IL-9 affects Th17 cells and Tregs is through activation of STAT3 and STAT5 signaling (Elyaman et al., 2009 ). Singh and colleagues have shown that IL-9 has a role in the development of psoriatic lesions through Th17 cell-associated inflammation and angiogenesis (Singh et al., 2013) . Zhou and colleagues have reported hat IL-9 induces chemokine CCL-20 production by astrocytes to enhance the infiltration of Th17 cells into the central nervous system . To the best of our knowledge, the current study was the first one to explore the impact of IL-17 on the differentiation and immune regulation of Th9 cells. The contribution of IL-17 or Th17 cells to tumor immunity has been well documented (Ye et al., 2013; Zou and Restifo, 2010) . Our previous studies showed that Th17 cell numbers in MPE are significantly increased, and that overrepresentation of Th17 cells in MPE may be due to Th17 cell differentiation and expansion stimulated by local proinflammatory cytokines, and to recruitment of Th17 cells from blood induced by pleural chemokines CCL20 and CCL22 (Ye et al., 2010) . On the other hand, Tregs inhibit the generation and differentiation of Th17 cells via a latency-associated peptide-dependent mechanism (Ye et al., 2011) . More recently, we have demonstrated that IL-17 deficiency promotes angiogenesis and proliferation activity of pleural tumors as well as pleural vascular permeability, and thus promotes MPE formation (Lin et al., 2014) . The finding that IL-17 deficiency accelerates the death of mice bearing MPE observed in the animal study (Lin et al., 2014) is consistent with the finding that the accumulation of Th17 cells in MPE predicts improved patient survival in the human study (Ye et al., 2010) . Consistent with our previous findings (Lin et al., 2014) , we confirmed that IL-17 deficiency promoted MPE formation by enhancing the angiogenesis and proliferation of pleural tumors, and that in vivo administration of anti-IL-17 mAb in WT mice was able to promote MPE formation by increasing tumor angiogenesis and proliferation, while in vivo administration of rmIL-17 in IL-17 / mice was able to inhibit MPE formation by diminishing tumor angiogenesis and proliferation. Previous studies have suggested that IL-9 plays an important role in NK/T-cell lymphoma possibly via an autocrine mechanism (Nagato et al., 2005) . Purwar and colleagues (Purwar et al., 2012) have demonstrated that that mice deficient in Th17 cell development have substantial resistance to melanoma growth in a IL-9-dependent manner; and treatment with exogenous IL-9 inhibits tumor growth in vivo. Lu and colleagues have found that tumor-infiltrating Th9 cells induce lung tumor tissues, especially epithelial cells, to express CCL20, which recruits inflammatory cells, especially dendritic cells, into tumor sites, and subsequently promotes a strong activation response of CD8 + tumor-infiltrating lymphocytes (Lu et al., 2012) . These data suggest a distinct role for tumor-specific Th9 cells in provoking CD8 + T cell-mediated anti-tumor immunity. On the other hand, intratumor Th2 cells have been shown to correlate with cancer-associated fibroblast thymic stromal lymphopoietin production and to reduce survival of cancer patients (De Monte et al., 2011) . The relationship between Th9 cells and Th2 cells is of particular interest, and their immune regulation is often linked to proinflammatory processes and tumor immunity. We therefore explored the distribution of Th9 cells in relation to Th2 cells in MPE and found that the numbers of both Th9 and Th2 cells in MPE were significantly higher than those in blood and spleen.Nevertheless the numbers of Th9 and Th2 cells were significantly lower in MPE, but not in either spleen or blood, from IL-17 / mice than those from WT mice, indicating that the differentiation of Th9 and Th2 cells in MPE can be promoted by IL-17 in vivo. Since IRF4 is a transcription factor that is essential for the developmental program of Th9 cells (Staudt et al., 2010; Tamiya et al., 2013) , and the differentiation of Th2 cell lineage requires the upregulation of GATA-3 (Zheng and Flavell, 1997; Zhou and Ouyang, 2003) , we thus examined mRNA expression of IL-9 and IL-4 simultaneously with mRNA expression of IRF4 and GATA-3, and found that there was much lower mRNA expression of IL-9 and IRF4 in MPE from IL-17 / mice than that from WT mice. Similarly, mRNA expression of IL-4 and GATA-3 was also lower in MPE from IL-17 / mice than that from WT mice.
Collectively, our data suggested that IL-17 enhances differentiation Th9 and Th2 cells by up-regulating expression of IRF4 and GATA-3, respectively. Our previous data showed that IL-9 significantly promotes the proliferation response and migratory activity of lung cancer cells by activating STAT3 signaling, and that IL-9 strongly promotes intercellular adhesion of lung cancer cells to pleural mesothelial cells by upregulating the expression of cellular adhesion molecules ICAM-1, LFA-1 and VCAM-1 on both cancer cells and pleural mesothelial cells (Ye et al., 2012b) . All these functional aspects of IL-9 provide the explanation for our observation that the accumulation of Th9 cells in MPE predicts reduced patient survival, with increased risk for death in MPE patients (Ye et al., 2012b) . In the present study, we noted a significant correlation between IL-17 deficiency and mouse survival. The absence of IL-17 was a significant predictor for short survival of MPE mice, intraperitoneal injection of anti-IL-9 neutralizing mAb accelerated the death of WT mice bearing MPE, and intraperitoneal injection of rmIL-9 improved the survival of IL-17 / mice bearing MPE. Our data indicate that IL-17 reduces the death of mice bearing MPE via IL-9-dependent mechanism.
In conclusion, we have demonstrated that both Th9 and Th2 cells were decreased in MPE from IL-17 / mice as compared with WT mice. IL-17 inhibits MPE formation by attenuating angiogenesis and proliferation of pleural tumor, and thus reduces the death of mice bearing MPE via IL-9-dependent mechanism. Thus, therapeutic intervention aiming at interfering Th17 or/and Th9 cells may be beneficial for improving prognosis in patients with MPE.
MATERIALS AND METHODS
Animals
Wild type (WT) C57BL/6 mice were purchased from the Animal Center of Wuhan University (Wuhan, China).
IL-17a
/ mice in a C57BL/6 background were generated as previously described (Nakae et al., 2002) and were provided by Dr. Iwakura (University of Tokyo, Japan 
MPE Model
A mouse model of MPE by intrapleural injecting Lewis lung cancer (LLC) cells was made as described previously (Lin et al., 2014) . Briefly, mice were anesthetized by isoflurane inhalation, the skin overlying the anterior and lateral chest wall was shaved and disinfected, and a 5-mm-long trans-verse skin incision was made on the right anterolateral thoracic area at the xiphoid level. Fascia and muscle were retracted, and 1.5×10 5 LLC cells (purchased from the American Type Culture Collection (Manassas, USA) suspended in 50 μL phosphate buffered saline (PBS) were injected into pleural cavity through an intercostal space under direct observation. The skin incision was closed using continuous 5-0 Ethilon monofilament suture, and the animals were monitored until complete recovery.
Sample collection and processing
Fourteen days after pleural injection of LLC cells, mice were euthanized by CO 2 asphyxiation, and blood was drawn from the retro-orbital veins. Thereafter, the abdominal wall was opened, and the viscera were retracted to visualize the diaphragm. Pleural fluid was gently aspirated using a 3-mL syringe, and its volume was measured with a 1,000-μL pipette. Smear slides were made from samples for WrightGiemsa staining and were determined for leukocyte differential counts under light microscope.
MPE and blood samples from each mouse were collected in heparin-treated tubes, and were immersed in ice immediately and were then centrifuged at 300×g for 10 min. In order to obtain spleen cell suspension, spleens were removed and cut into small pieces, and then minced in PBS and filtered. The cell pellets of MPE, blood, and spleen were resuspended in PBS, and mononuclear cells were isolated by Ficoll-Hypaque gradient centrifugation (Pharmacia, Sweden) to determine T cell subsets within 1 h.
In vivo treatment of mice
At days 1, 3, 6, 9, and 12 after intrapleural instillation of LLC cells, WT mice (n=10) received intraperitoneal injection of 100 µg anti-IL17A neutralizing mAb (clone eBioMM17F3, eBioscience, lgG1, USA) or 100 µg mouse IgG1 isotype control mAb (eBioscience); while IL-17 / mice were injected intraperitoneally at a dose of 1 μg recombinant mouse (rm) IL17A diluted in PBS containing 0.1% albumin (R&D System, USA) or PBS containing 0.1% albumin in a total volume of 100 μL. The administration regimens of anti-IL-17 mAb and rmIL-17 were based upon our preliminary experiments.
Positron emission tomography (PET) and computed tomography (CT) scanning
All PET images were acquired using Trans-PET ® BioCaliburn TM LH (Raycan Technology Co., Ltd, Suzhou) consisting of 12 basic detector modules. Fifteen-min PET scans were begun between 60 and 70 min after retro-orbital injection of 200-300 μCi of 18-fluoro-6-deoxy-glucose. In consideration of the PET system's spatial resolution, reconstructed PET images had pixel dimensions of (0.5 mm) 2 and 0.5 mm slice thickness. Furthermore, due to the OSEM reconstruction method using point spread function system response matrix, the size of the reconstructed 3D image was set to be 280×280×104 (X×Y×Z) that must be smaller than or equal to the size of point spread function system response matrix. Also, CT images were acquired on a small animal CT scanner provided by the Trans-PET system with characteristics of an axial field of view of 5.0 cm, a radial field of view of 7.0 cm and a spatial resolution of 0.5 mm. The PET and CT images were acquired with the mouse under anesthesia in a common animal holder. The co-registration of the images was implemented using the AMIDE software package (The Free Software Foundation Inc., USA).
Immunofluorescence staining
Pleural tumor tissues were fixed in 4% paraformaldehyde, embedded with paraffin. The paraffin-embedded tissues were cut into 5-µm thick sections that were mounted on glass slides. The primary Abs were rat anti-mouse CD34 mAb (both were purchased from Abcam, UK) and rabbit mAb targeted against mouse Ki-67, appropriate species-matched Abs were used as isotype controls. As secondary Abs, dylight 488-conjugated affinity-purified goat anti-rat IgG (EarthOx, USA) was used for labeling the rat anti-mouse CD34 mAb, and cy3-conjugated affinity-purified goat anti-rabbit IgG (Proteintech Group Inc, USA) was used for labeling the rabbit anti-mouse Ki-67 Ab. The slides were processed and then incubated with 10% goat serum in PBS at room temperature for 30 min, and then incubated at 4°C overnight with 1/500 concentrations of primary Abs. After washing, slides were incubated with secondary Abs for 120 min at room temperature in the dark. 4′,6-diamidino-2-phenylindole mounting medium (Vector Laboratories, USA) was used for cell nuclei staining. Finally, slides were examined under laser scanning confocal microscope (Olympus FV500; Olympus, Japan).
Flow cytometry
For intracellular detection of cytokines, cells were stimulated for 4 h at 37°C with 50 ng mL 1 PMA (Sigma-Aldrich, USA) and 1 μg mL 1 ionomycin (Sigma-Aldrich) in the presence of Brefeldin A (10 µg mL 1 , Enzo Life Science, USA). The Abs including anti-CD3, -CD8, -IL-4, -GATA-3, and -interferon-regulatory factor 4 (IRF4) mAbs were purchased from BDPharmingen (San Diego, USA) or eBioscience (San Diego). Cells were surface-stained with anti-CD3 and -CD8 mAbs in PBS+2% heat-inactivated fetal bovine serum (FBS, Gibco, USA) for 20 min at 4°C. Cells were resuspended in a fixation/permeabilization solution (Cytofix/Cytoperm; BD Pharmingen, USA) and incubated with anti-IL-4, -IL-9, -GATA-3 or -IRF4 mAbs for 30 min at 4°C. Cells were then washed with permeabilization buffer and resuspended in PBS+2% FBS for flow cytometric analysis (FACSCanto II; BD Bioscience, USA). Flow cytometry was performed on a FACS Canto II (BD Biosciences) and analyzed using BD FCSDiva Software and FCS Express 4 software (De Novo Software, USA).
Quantitative real time PCR
Total RNA was isolated from cell pellets with Trizol reagent (Invitrogen, USA). cDNAs were synthesized with oligo (dT) primers using the First Strand cDNA Synthesis Kit ReverTra Ace--(TOYOBO, Japan). cDNAs were used as templates in real time PCR with the SYBR Green I Real time PCR Master Mix (TOYOBO). DNA was amplified under the following typical cycling conditions: denaturation at 95°C for 15 s, annealing at 58°C for 20 s, extension at 72°C for 20 s. The samples were amplified for 40 cycles.
The following primers were used: for il4, forward primer: 5′-TGTCATCCTGCTCTTCTTTCTC-3′, reverse primer: 5′-CACTCTCTGTGGTGTTCTTCGT-3′; for il9, forward primer: 5′-GGTGACATACATCCTTGCCTCT-3′, reverse primer: 5′-CCCTCCCTGTAGCACGGT-3′; for gata3, forward primer: 5′-TTACCACCTATCCGCCCTA-3′ reverse primer: 5′-ACACTCCCTGCCTTCTGTG-3′; for irf4, forward primer: 5′-CAATGTCCTGTGACGTTTGG-3′, reverse primer: 5′-GGCTTCAGCAGACCTTATGC-3′; for -actin, forward primer: 5′-CTGAGAGGGAAATCGTG-CGT-3′, reverse primer: 5′-CCACAGGATTCCATACCC-AAGA-3′. -actin was used as an internal control, and levels of each gene were normalized to -actin expression using the ∆∆Ct-method, with WT mouse experimental value set to 1. PCR products were also analyzed in 2% agarose gel electrophoresis.
Survival advantage
The observation of survival advantage included 3 groups of WT and 3 groups of IL-17 / mice (each n=15). At days 1, 3, 6, 9, and 12 after intrapleural instillation of LLC cells, 2 groups of WT mice received intraperitoneal injection of 100 µg anti-IL-9 neutralizing mAb (clone D9302C12, eBioscience) (WT+anti-IL-9) or 100 µg mouse isotype control mAb (eBioscience), respectively; and 2 groups of IL-17 / mice received intraperitoneal injection of 1 μg rmIL-9 (R&D-System, USA) diluted in PBS containing 0.1% albumin (IL-17 / +rmIL-9) or PBS containing 0.1% albumin in a total volume of 200 μL, respectively. One group of WT and 1 group of IL-17 / mice receiving no intraperitoneal injections served as controls. The mice without heartbeat and breathing were determined to be dead. The doses of anti-IL-9 mAb and rmIL-9 were based upon our preliminary experiments.
Statistics
Data were normally distributed, and all values are expressed as mean±SE. Differences between two or multiple experimental groups were compared using Student's t test, one-way analysis of variance (ANOVA), or two-way ANOVA, as appropriate. Survival was estimated by the Kaplan-Meier method and compared by the log-rank test. Analysis was completed with SPSS version 16.0 Statistical Software (USA), and P<0.05 was considered to indicate statistical significance.
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